Spravato® (esketamine) is an FDA-approved prescription treatment designed for adults experiencing treatment-resistant depression and certain forms of major depressive disorder. Unlike traditional antidepressants, which primarily target serotonin, norepinephrine, or dopamine systems, Spravato works through different pathways in the brain associated with mood regulation, learning, and neural connectivity.
Administered as a nasal spray under medical supervision, Spravato is used alongside an oral antidepressant as part of a comprehensive treatment plan. For some individuals who have struggled to find relief through traditional approaches alone, Spravato offers an additional option that may help reduce depressive symptoms and improve quality of life.
Everyone’s experience with depression is different. While many people respond well to therapy, medication, or a combination of both, others continue to experience significant symptoms despite trying multiple treatment approaches.
Spravato may be helpful for individuals who:
For some individuals, Spravato offers a different path forward when traditional treatments have not produced the results they hoped for.
Spravato may be appropriate for adults who have experienced limited improvement after trying multiple antidepressant medications. Many individuals who pursue Spravato describe feeling frustrated by repeated medication changes, lingering symptoms, or a sense that traditional approaches have not fully addressed their depression.
Treatment may also be beneficial for individuals seeking a more comprehensive approach to depression care under the supervision of an experienced psychiatric provider. Determining whether Spravato is appropriate requires a thorough evaluation of symptoms, treatment history, medical considerations, and personal goals.
Not everyone is a candidate for Spravato, which is why careful assessment and ongoing monitoring are essential parts of the process.
At Daybreak Counseling, Spravato treatment is integrated into a broader mental health care plan. Medication is rarely the entire solution, which is why we encourage a collaborative approach that may include therapy, lifestyle support, and ongoing medication management when appropriate.
Our goal is to help clients find meaningful relief while feeling informed, supported, and empowered throughout the process.
Spravato contains esketamine, a derivative of ketamine, but it is an FDA-approved prescription treatment administered under medical supervision.
Every individual responds differently. Some people notice improvement relatively quickly, while others experience more gradual changes over time.
Many individuals benefit from combining medication treatment with therapy to address both symptoms and underlying concerns.
Coverage varies by plan and authorization requirements. Our team can help review eligibility and discuss next steps.
If depression continues to impact your daily life despite previous treatment efforts, Spravato may be worth exploring.
Contact Daybreak Counseling today to schedule a consultation with Holly Bulver and learn whether Spravato treatment may be right for you.
